| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |